DARS2 and hepatocellular carcinoma: DARS2 (mitochondrial aspartyl-tRNA synthetase) was strongly upregulated in HCC, and the increase in DARS2 expression was correlated with tumor size, cell differentiation, distal metastasis, and portal vein invasion in HCC and a shorter survival time.